# Treatment of Hematologic Malignancies With Single-Unit or Double-Unit Cord Blood Transplantation

> **NCT00328237** · PHASE2 · UNKNOWN · sponsor: **Colorado Blood Cancer Institute** · enrollment: 20 (—)

## Conditions studied

- Acute Myeloid Leukemia
- Acute Lymphoblastic Leukemia
- Chronic Myeloid Leukemia
- Non-Hodgkin Lymphoma
- Myelodysplastic Syndromes

## Interventions

- **PROCEDURE:** Cord Blood Transplant

## Key facts

- **NCT ID:** NCT00328237
- **Lead sponsor:** Colorado Blood Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2005-11
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 20 (—)
- **Last updated:** 2006-06-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00328237

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00328237, "Treatment of Hematologic Malignancies With Single-Unit or Double-Unit Cord Blood Transplantation". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00328237. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*